The market size for Penicillins and Streptomycins in Brazil has shown a pattern of fluctuations over the past decade. Starting at $381.22 million in 2012, the value saw both dips and rises, closing at $407.83 million in 2022. Notable increases were observed from 2014 to 2015 (6.62% and 6.21% respectively) and again from 2017 to 2018 (7.95% and 7.36%), while significant declines occurred in 2019 (-7.96%) and 2020 (-5.75%). Over the last two years (2021–2022), the market saw a positive variation of 8% in 2021 followed by a decrease of 4.68% in 2022. The average compound annual growth rate (CAGR) for the last five years stands at -0.84%, reflecting an overall mild contraction in the market.
Future trends to watch for include the potential impact of advancements in antibiotic alternatives, shifts in healthcare policies, and market responses to emerging global health concerns. Continuous monitoring of these factors will be essential for anticipating changes in market dynamics.
How does Brazil rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 6 | 6 Brazil | 451,970,000 | 2023 | +1.29% | -0.21% | |
| 7 | 7 Australia | 260,610,000 | 2023 | +1.79% | +1.42% | View data |
| 8 | 8 Vietnam | 256,220,000 | 2023 | +4.62% | +6.03% | View data |
